Glycosylation of microtubule–associated protein tau: An abnormal posttranslational modification in Alzheimer's disease
Abstract
Alzheimer's disease (AD) is characterized by the presence of numerous neurons with neurofibrillary tangles of paired helical filaments (PHFs). The microtubule-associated protein tau in abnormally hyperphosphorylated form is the major protein subunit of the PHF. We now show that PHF tangles isolated from AD brains are glycosylated, whereas no glycan is detected in normal tau. Deglycosylation of PHF tangles by endoglycosidase F/N-glycosidase F converts them into bundles of straight filaments 2.5 +/- 0.5 nm in diameter, similar to those generated by the interaction of normal tau and abnormally hyperphosphorylated tau (AD P-tau). Deglycosylation plus dephosphorylation, but not deglycosylation alone, of AD P-tau and tau from PHF tangles restores their microtubule polymerization activity. Dephosphorylation of deglycosylated PHF tangles results in increased tau release. Thus, although the abnormal phosphorylation might promote aggregation of tau and inhibition of the assembly of microtubules, glycosylation appears to be responsible for the maintenance of the PHF structure.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
N-glycosylation has been detected in PHF-tau isolated from AD brains, but not in healthy brain.
“N-glycosylation has been detected in PHF-tau isolated from AD brains, but not in healthy brain [182].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [182]
Both N- and O-linked glycosylation have been identified in tau.
“Both N- and O-linked glycosylation have been identified in tau [182, 183].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [182]
Reduced tau O-glycosylation could lead to increased phosphorylation, while enhancement of O-glycosylation reduces the extent of tau phosphorylation.
“For example, reduced tau O-glycosylation could lead to increased phosphorylation, while the enhancement of O-glycosylation reduces the extent of tau phosphorylation [43–45].”
From Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation (2023) · cites this paper as [45]
N-glycosylation of tau is increased in AD and is thought to promote phosphorylation and pathological conformational changes.
“Conversely, N-glycosylation of tau, which is thought to promote phosphorylation and pathological conformational changes, is increased in AD9,35.”
From Tau-targeting therapies for Alzheimer disease (2018) · cites this paper as [9]
The citation lists haven’t been fetched yet
References 34 · Cited by 360
- Authors
- Wang, J.-Z., Grundke-Iqbal, I., & Iqbal, K.
- Venue
- Nature Medicine
- Published
- 1996-08
- Volume
- 2
- Issue
- 8
- Pages
- 871-875
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1964358104
- Cited by
- 360
- References
- 34
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 13 · 2023: 8 · 2022: 19 · 2021: 24 · 2020: 25 · 2019: 23 · 2018: 20 · 2017: 18 · 2016: 5 · 2015: 12 · 2014: 9 · 2013: 10 · 2012: 9
- FWCI
- 8.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag008076-09, 5r01ag005892-16)
- National Institute on Aging (AG-05892, AG 08076)
- National Institute of Mental Health (MH.NS 31862)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- tau protein, glycosylation, Alzheimer's disease, paired helical filaments, neurofibrillary tangles, hyperphosphorylation, deglycosylation, N-glycosidase F, endoglycosidase F, microtubule assembly, tau aggregation, post-translational modification
- MeSH terms
- Alzheimer Disease, Animals, Brain, Cattle, Glycosylation, Humans, Polysaccharides, Protein Processing, Post-Translational, Neurofibrillary Tangles, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review